CHANGZHOU, China--(BUSINESS WIRE)--China Kanghui Holdings (NYSE: KH), a leading domestic developer, manufacturer and marketer of orthopedic implants in China, today announced that the company will present at Morgan Stanley’s 2nd Annual Hong Kong Investor Summit on May 20, 2011 and meet with institutional investors throughout the day.
The summit will be held at the Morgan Stanley International Commerce Center, 1 Austin Road, West Kowloon, Hong Kong.
Investors interested in attending the summit and meeting with representatives from Kanghui, please contact a Morgan Stanley sales representative.
About China Kanghui Holdings
Founded in 1997, Kanghui is a leading domestic developer, manufacturer and marketer of orthopedic implants in China. The Company offers a wide array of proprietary orthopedic implant products in trauma and spine. It has an extensive network of distributors for its products in China. In addition, Kanghui's products are distributed in 24 countries. Kanghui has strong research and development capabilities, focused on developing new proprietary products, including new product lines, extensions of existing product lines and enhancements of existing products. For more information, please visit www.kanghui.com.
Contacts
Asia Bridge Capital Limited
Susan Stillings, +1-415-800-4428
susan.stillings@asiabridgegroup.com
or
Carene Toh, +86-186-1835-6339
carene.toh@asiabridgegroup.com